Activated phosphoinositide 3-kinase δ syndrome (APDS): Challenges in diagnosis, management and recent advances in treatment

Activated phosphoinositide 3-kinase δ syndrome (APDS): Challenges in diagnosis, management and recent advances in treatment

Introduction from Chair

Anna Sediva

APDS: diagnosis and management

Anita Chandra

Scientific exchange session: Phase 3 safety and efficacy data of leniolisib, an investigational treatment for APDS

Virgil A. Dalm